Essent Group Likely To Report Lower Q2 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Essent Group (ESNT) is set to report second-quarter earnings on August 8, with analysts projecting a decline in EPS to $1.71 from $1.91 year-over-year, while revenue is expected to increase to $317.85 million from $312.94 million. This follows a better-than-expected Q1 performance. Analyst sentiment is mixed but generally supportive, featuring a recent downgrade to Market Perform by Keefe, Bruyette & Woods and a price target cut by Goldman Sachs, yet balanced by a J.P. Morgan upgrade to Overweight and maintained Buy/Outperform ratings from Compass Point and RBC Capital, with most price targets exceeding the current $57.02 share price.

Analysis

Essent Group (ESNT) is approaching its second-quarter earnings release with consensus estimates pointing to a divergence in top and bottom-line performance. Analysts project quarterly earnings per share will decline to $1.71 from $1.91 in the prior-year period, a 10.5% decrease, while revenue is expected to see a modest 1.6% year-over-year increase to $317.85 million. This follows a better-than-expected first quarter, setting a precedent for potential performance against these mixed expectations. The stock's recent 1.4% decline to $57.02 suggests some investor caution. Analyst sentiment is nuanced; while Keefe, Bruyette & Woods recently downgraded the stock to Market Perform, they simultaneously raised their price target to $67, indicating the move may be valuation-based rather than a fundamental concern. This is balanced by a recent upgrade to Overweight from JP Morgan and maintained Buy/Outperform ratings from Compass Point and RBC Capital, with price targets ranging from $60 to $69, all suggesting upside from the current price.

Key Decisions for Investors

• Investors should focus on whether Essent Group can beat the lowered EPS estimate of $1.71 and provide strong forward guidance, as this will be the key catalyst given the projected year-over-year earnings decline.
• The recent analyst downgrade to Market Perform, despite a price target increase to $67, suggests the stock may be perceived as fairly valued, warranting a review of position sizing ahead of a potential catalyst.
• Consider the risk presented by the forecasted margin compression, where revenue grows but EPS falls, and weigh this against the consensus analyst view that the stock has upside potential to a price range of $60-$69.